Showing results (31-40 of 208) with videos related to

Sort By:
Pageof 21
Bioorganic & Medicinal Chemistry|July 12, 2014
Bradykinin antagonists and thiazolidinone derivatives as new potential anti-cancer compoundsStanislav Avdieiev, Lajos Gera, Dmytro Havrylyuk, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
High level of glutathione-S-transferase pi expression in mantle cell lymphomasAnnelise Bennaceur-Griscelli, Jacques Bosq, Serge Koscielny, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 6, 2007
Imaging of the distribution of (90)y-ibritumomab tiuxetan in bone marrow and comparison with pathologyJeremy Coulot, Valérie Camara-Clayette, Marcel Ricard, et al.
European Journal of Cancer (Oxford, England : 1990)|September 12, 2017
Challenges and perspectives in the immunotherapy of Hodgkin lymphomaJean-Marie Michot, Julien Lazarovici, David Ghez, et al.
Human Vaccines & Immunotherapeutics|June 8, 2021
Relapsed and refractory classical Hodgkin lymphoma: could virotherapy help solve the equation?Selma Addou, Clémentine Sarkozy, Julien Lazarovici, et al.
Journal of Neurology|June 18, 2016
Is distal motor and/or sensory demyelination a distinctive feature of anti-MAG neuropathy?Pierre Lozeron, Vincent Ribrag, David Adams, et al.
Blood|September 5, 2008
Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosisVincent Ribrag, Serge Koscielny, Olivier Casasnovas, et al.
Leukemia Research|December 23, 2014
A phase I, open-label, multi-center study of the JAK2 inhibitor AZD1480 in patients with myelofibrosisSrdan Verstovsek, Ronald Hoffman, John Mascarenhas, et al.
Plos One|September 27, 2013
BMP7 expression correlates with secondary drug resistance in mantle cell lymphomaValérie Camara-Clayette, Serge Koscielny, Sébastien Roux, et al.
Pageof 21